Monovalent and multivalent inhibitors of bacterial toxins

Synthesis and Biological Applications of Glycoconjugates

Volumn , Issue , 2011, Pages 78-91

  Hayes, Edward D ^a   Bruce Turnbull, W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Bacterial toxin; Cholera; Dendrimer; Inhibitor; Multivalency

Indexed keywords

EID: 84882883517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805277611101010078     Document Type: Chapter

References (102)

1. Bhattacharya, S.K. An evaluation of current cholera treatment. Exp. Opin. Pharmacother., 2003, 4, 141-146.
2. Sánchez, J.; Holmgren, J. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr. Opin. Immunol., 2005, 17, 388-398.
3. World Health Organisation. Communicable Diseases, 2003, 74-79.
4. Anon. Cholera vaccines: WHO position paper Wkly Epidemiol. Rec., 2010, 85, 117-128.
5. Chambers, K. Zimbabwe's battle against cholera. Lancet, 2009, 373, 993-994.
6. Penrose, K.; de Castro, M.C.; Werema, J.; Ryan, E.T. Informal urban settlements and cholera risk in Dar Es Salaam, Tanzania. PLoS Negl. Trop. Dis., 2010, 4.
7. Anon. Cholera: Global surveillance summary, 2008. Wkly Epidemiol. Rec., 2009, 84, 309-324.
8. Fisher, D. Cholera in Zimbabwe. Ann. Acad. Med. Singapore, 2009, 38, 82-83.
9. Sack, D.A.; Sack, R.B.; Nair, G.B.; Siddique, A.K. Cholera. Lancet, 2004, 363, 223-233.
10. Svennerholm, A.M.; Steele, D. Progress in enteric vaccine development. Best Pract Res Clin Gastroenterol, 2004, 18, 421-445.
11. Zuckerman, J.N.; Rombo, L.; Fisch, A. The true burden and risk of cholera: Implications for prevention and control. Lancet Infect. Dis., 2007, 7, 521-530.
12. Mekalanos, J.J.; Swartz, D.J.; Pearson, G.D.N.; Harford, N.; Groyne, F.; Dewilde, M. Cholera-toxin genes - nucleotidesequence, deletion analysis and vaccine development. Nature, 1983, 306, 551-557.
13. Spangler, B.D. Structure and function of cholera-toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev., 1992, 56, 622-647.
14. Clements, J.D.; Finkelstein, R.A. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli. Infect. Immun., 1978, 22, 709-713.
15. Sixma, T.K.; Pronk, S.E.; Kalk, K.H.; Wartna, E.S.; Vanzanten, B.A.M.; Witholt, B.; Hol, W.G.J. Crystal-structure of a cholera toxin-related heat-labile enterotoxin from Escherichia coli. Nature 1991, 351, 371-377.
16. O'Neal, C.J.; Amaya, E.I.; Jobling, M.G.; Holmes, R.K.; Hol, W.G.J. Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism. Biochemistry, 2004, 43, 3772-3782.
17. Merritt, E.A.; Hol, W.G.J. AB5 toxins. Curr. Opin. Struct. Biol., 1995, 5, 165-171.
18. Pande, A.H.; Scaglione, P.; Taylor, M.; Nemec, K.N.; Tuthill, S.; Moe, D.; Holmes, R.K.; Tatulian, S.A.; Teter, K. Conformational instability of the cholera toxin A1 polypeptide. J. Mol. Biol., 2007, 374, 1114-1128.
19. Sanchez, J.; Holmgren, J. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr. Opin. Immunol., 2005, 17, 388-398.
20. Mekalanos, J.J.; Collier, R..; Romig, W.R. Enzymic activity of cholera toxin II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J. Biol. Chem., 1979, 254, 5855-5861.
21. De Haan, L.; Hirst, T.R. Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms. Mol. Membr. Biol., 2004, 21, 77-92.
22. Tsai, B.; Rodighiero, C.; Lencer, W.I.; Rapoport, T.A. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell, 2001, 104, 937-948.
23. Sanchez, J.; Holmgren, J. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell. Mol. Life Sci., 2008, 65, 1347-1360.
24. Gill, D.M. Mechanism of action of cholera toxin. Adv. Cyclic Nucleotide Res., 1977, 8, 85-118.
25. Johnson, G.L.; Kaslow, H.R.; Bourne, H.R. Genetic evidence that cholera toxin substrates are regulatory components of adenylate-cyclase. J. Biol. Chem., 1978, 253, 7120-7123.
26. Gill, D.M.; Meren, R. ADP-ribosylation of membrane proteins catalyzed by cholera toxin - basis of activation of adenylate-cyclase. Proc. Natl. Acad. Sci. USA, 1978, 75, 3050-3054.
27. Cassel, D.; Selinger, Z. Mechanism of adenylate-cyclase activation by cholera toxin - inhibition of GTP hydrolysis at regulatory site. Proc. Natl. Acad. Sci. USA, 1977, 74, 3307-3311.
28. Salmond, R.J.; Luross, J.A.; Williams, N.A. Immune modulation by the cholera-like enterotoxins. Exp. Rev. Mol. Med., 2002, 4, 1-16.
29. Zhang, G.T. Design and in silico screening of inhibitors of the cholera toxin. Exp. Opin. Drug Disc., 2009, 4, 923-938.
30. Tsai, B.; Rapoport, T.A. Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by ERO1. J. Cell Biol., 2002, 159, 207-215.
31. Gill, D.M. Arrangement of subunits in cholera toxin. Biochemistry, 1976, 15, 1242-1248.
32. Lonnroth, I.; Holmgren, J. Subunit structure of cholera toxin. J. Gen. Microbiol., 1973, 76, 417-427.
33. Hovey, B.T.; Verlinde, C.L.M.J.; Merritt, E.A.; Hol, W.G.J. Structure-based discovery of a pore-binding ligand: Towards assembly inhibitors for cholera and related AB5 toxins. J. Mol. Biol., 1999, 285, 1169-1178.
34. van Heyningen, S. Cholera Toxin: interaction of subunits with ganglioside GM1. Science, 1974, 183, 656-657.
35. Merritt, E.A.; Sarfaty, S.; Vandenakker, F.; Lhoir, C.; Martial, J.A.; Hol, W.G.J. Crystal-structure of cholera-toxin Bpentamer bound to receptor GM1 pentasaccharide. Protein Sci., 1994, 3, 166-175.
36. Merritt, E.A.; Kuhn, P.; Sarfaty, S.; Erbe, J.L.; Holmes, R.K.; Hol, W.G.J. The 1.25 Å resolution refinement of the cholera toxin B-pentamer: Evidence of peptide backbone strain at the receptor-binding site. J. Mol. Biol., 1998, 282, 1043-1059.
37. Schon, A.; Freire, E. Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry, 1989, 28, 5019-24.
38. Masserini, M.; Freire, E.; Palestini, P.; Calappi, E.; Tettamanti, G. Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin. Biochemistry, 1992, 31, 2422-2426.
39. Picking, W.L.; Moon, H.; Wu, H.; Picking, W.D. Fluorescence analysis of the interaction between ganglioside GM1- containing phospholipid vesicles and the B subunit of cholera toxin. Biochim. Biophys. Acta, 1995, 1247, 65-73.
40. Kuziemko, G.M.; Stroh, M.; Stevens, R.C. Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry, 1996, 35, 6375-6384.
41. Mertz, J.A.; McCann, J.A.; Picking, W.D. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin b subunit. Biochem. Biophys. Res. Commun., 1996, 226, 140-144.
42. MacKenzie, C.R.; Hirama, T.; Lee, K.K.; Altman, E.; Young, N.M. Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J. Biol. Chem., 1997, 272, 5533-5538.
43. Cai, X.-E.; Yang, J. The binding potential between the cholera toxin B-oligomer and its receptor. Biochemistry, 2003, 42, 4028-4034.
44. Turnbull, W.B.; Precious, B.L.; Homans, S.W. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J. Am. Chem. Soc., 2004, 126, 1047-1054.
45. Fan, E.; O'Neal, C.J.; Mitchell, D.D.; Robien, M.A.; Zhang, Z.; Pickens, J.C.; Tan, X.-J.; Korotkov, K.; Roach, C.; Krumm, B.; Verlinde, C.L.M.J.; Merritt, E.A.; Hol, W.G.J. Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin. Int. J. Med. Microbiol., 2004, 294, 217-223.
46. Bernardi, A.; Potenza, D.; Capelli, A.M.; Garcia-Herrero, A.; Canada, F. J.; Jimenez-Barbero, J. Second-generation mimics of ganglioside GM1 oligosaccharide: A three-dimensional view of their interactions with bacterial enterotoxins by nmr and computational methods. Chem. Eur. J., 2002, 8, 4597-4612.
47. Gorbach, S.L.; Banwell, J.G.; Chatterj. B.D.; Jacobs, B.; Sack, R.B. Acute undifferentiated human diarrhea in tropics. Alterations in intestinal microflora. J. Clin. Invest., 1971, 50, 881-889.
48. Rowe, B.; Taylor, J.; Bettelhe, K.A. An investigation of travellers diarrhoea. Lancet, 1970, 1, 1-5.
49. Gyles, C.L.; Barnum, D.A. A heat-labile enterotoxin from strains of Escherichia coli enteropathogenic for pigs. J. Infect. Dis., 1969, 120, 419-426.
50. Merritt, E.A.; Sixma, T.K.; Kalk, K.H.; Vanzanten, B.A.M.; Hol, W.G.J. Galactose-binding site in escherichia-coli heatlabile enterotoxin (LT) and cholera-toxin (CT). Mol. Microbiol., 1994, 13, 745-753.
51. Dallas, W.S.; Falkow, S. Amino-acid-sequence homology between cholera-toxin and Escherichia coli heat-labile toxin. Nature, 1980, 288, 499-501.
52. Fan, E.; Merritt, E.A.; Zhang, Z.; Pickens, J.C.; Roach, C.; Ahn, M.; Hol, W.G.J. Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Acta Cryst. D: Biol. Cryst., 2001, D57, 201-212.
53. Velter, I.A.; Politi, M.; Podlipnik, C.; Nicotra, F. Natural and synthetic cholera toxin antagonists. Mini Rev. Med. Chem., 2007, 7, 159-170.
54. Zhang, G. Design, synthesis, and evaluation of bisubstrate analog inhibitors of cholera toxin. Bioorg. Med. Chem. Lett., 2008, 18, 3724-3727.
55. Zhou, G.-C.; Parikh, S.L.; Tyler, P.C.; Evans, G.B.; Furneaux, R.H.; Zubkova, O.V.; Benjes, P.A.; Schramm, V.L. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states. J. Am. Chem. Soc., 2004, 126, 5690-5698.
56. Hasegawa, A.; Ishida, H.; Nagahama, T.; Kiso, M. Synthetic studies on sialoglycoconjugates 48 - total synthesis of gangliosides GM1 and GD1a. J. Carbohydr. Chem., 1993, 12, 703-718.
57. Stauch, T.; Greilich, U.; Schmidt, R.R. Glycosyl imidates.73. Synthesis of ganglioside GM(1) via a GA(1) intermediate. Liebigs Ann., 1995, 2101-2111.
58. Sugimoto, M.; Numata, M.; Koike, K.; Nakahara, Y.; Ogawa, T. Synthetic studies on cell-surface glycans.50. Total synthesis of gangliosides GM1 and GM2. Carbohydr. Res., 1986, 156, C1-C5.
59. Bhattacharya, S.K.; Danishefsky, S.J. A total synthesis of the methyl glycoside of ganglioside GM(1). J. Org. Chem., 2000, 65, 144-151.
60. Blixt, O.; Vasiliu, D.; Allin, K.; Jacobsen, N.; Warnock, D.; Razi, N.; Paulson, J.C.; Bernatchez, S.; Gilbert, M.; Wakarchuk, W. Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a. Carbohydr. Res., 2005, 340, 1963-1972.
61. Pukin, A.V.; Weijers, C.A.G.M.; van Lagen, B.; Wechselberger, R.; Sun, B.; Gilbert, M.; Karwaski, M.-F.; Florack, D.E.A.; Jacobs, B.C.; Tio-Gillen, A.P.; van Belkum, A.; Endtz, H.P.; Visser, G.M.; Zuilhof, H. GM3, GM2 and GM1 mimics designed for biosensing: Chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis. Carbohydr. Res., 2008, 343, 636-650.
62. Acquotti, D.; Poppe, L.; Dabrowski, J.; Von der Lieth, C.W.; Sonnino, S.; Tettamanti, G. Three-dimensional structure of the oligosaccharide chain of GM1 ganglioside revealed by a distance-mapping procedure: A rotating and laboratory frame nuclear overhauser enhancement investigation of native glycolipid in dimethyl sulfoxide and in waterdodecylphosphocholine solutions. J. Am. Chem. Soc., 1990, 112, 7772-7778.
63. Richardson, J.M.; Milton, M.J.; Homans, S.W. Solution dynamics of the oligosaccharide moiety of ganglioside GM1: Comparison of solution conformations with the bound state conformation in association with cholera toxin b-pentamer. J. Mol. Recognit., 1995, 8, 358-362.
64. Bernardi, A.; Raimondi, L. Conformational analysis of gm1 oligosaccharide in water solution with a new set of parameters for the Neu5Ac moiety. J. Org. Chem., 1995, 60, 3370-3377.
65. Bernardi, A.; Boschin, G.; Checchia, A.; Lattanzio, M.; Manzoni, L.; Potenza, D.; Scolastico, C. Synthesis of a pseudo tetrasaccharide mimic of ganglioside GM1. Eur. J. Org. Chem., 1999, 1311-1317.
66. Bernardi, A.; Checchia, A.; Brocca, P.; Sonnino, S.; Zuccotto, F. Sugar mimics: An artificial receptor for cholera toxin. J. Am. Chem. Soc., 1999, 121, 2032-2036.
67. Bernardi, A.; Carrettoni, L.; Ciponte, A.G.; Monti, D.; Sonnino, S. Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: Replacement of the sialic acid moiety. Bioorg. Med. Chem. Lett., 2000, 10, 2197-2200.
68. Bernardi, A.; Arosio, D.; Manzoni, L.; Monti, D.; Posteri, H.; Potenza, D.; Mari, S.; Jimenez-Barbero, J. Mimics of ganglioside GM1 as cholera toxin ligands: Replacement of the GalNAc residue. Org. Biomol. Chem., 2003, 1, 785-792.
69. Arosio, D.; Baretti, S.; Cattaldo, S.; Potenza, D.; Bernardi, A. Ganglioside GM1 mimics: Lipophilic substituents improve affinity for cholera toxin. Bioorg. Med. Chem. Lett., 2003, 13, 3831-3834.
70. Cheshev, P.; Morelli, L.; Marchesi, M.; Podlipnik, C.; Bergstrom, M.; Bernardi, A. Synthesis and affinity evaluation of a small library of bidentate cholera toxin ligands: Towards nonhydrolyzable ganglioside mimics. Chem. Eur. J., 2010, 16, 1951-1967.
71. Minke, W.E.; Hong, F.; Verlinde, C.L.M.J.; Hol, W.G.J.; Fan, E. Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxin. J. Biol. Chem., 1999, 274, 33469-33473.
72. Vrasidas, I.; De Mol, N.J.; Liskamp, R.M.J.; Pieters, R.J. Synthesis of lactose dendrimers and multivalency effects in binding to the cholera toxin b subunit. Eur. J. Org. Chem., 2001, 4685-4692.
73. Vrasidas, I.; Kemmink, J.; Liskamp, R.M.J.; Pieters, R.J. Synthesis and cholera toxin binding properties of a lactose-2- aminothiazoline conjugate. Org. Lett., 2002, 4, 1807-1808.
74. Minke, W.E.; Roach, C.; Hol, W.G.J.; Verlinde, C.L.M.J. Structure-based exploration of the ganglioside GM1 binding sites of escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Biochemistry, 1999, 38, 5684-5692.
75. Pickens, J.C.; Merritt, E.A.; Ahn, M.; Verlinde, C.; Hol, W.G.J.; Fan, E.K. Anchor-based design of improved cholera toxin and E-coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Chem. Biol., 2002, 9, 215-224.
76. Podlipnik, C.; Bernardi, A. Design of a focused virtual library to explore cholera toxin b-site. Acta Chim. Slov., 2007, 54, 425-436.
77. Podlipnik, C.; Velter, I.; La Ferla, B.; Marcou, G.; Belvisi, L.; Nicotra, F.; Bernardi, A. First round of a focused library of cholera toxin inhibitors. Carbohydr. Res., 2007, 342, 1651-1660.
78. Arosio, D.; Fontanella, M.; Baldini, L.; Mauri, L.; Bernardi, A.; Casnati, A.; Sansone, F.; Ungaro, R. A synthetic divalent cholera toxin glycocalix[4]arene ligand having higher affinity than natural gm1 oligosaccharide. J. Am. Chem. Soc., 2005, 127, 3660-3661.
79. Fan, E.; Zhang, Z.; Minke, W.E.; Hou, Z.; Verlinde, C.L.M.J.; Hol, W.G.J. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J. Am. Chem. Soc., 2000, 122, 2663-2664.
80. Schengrund, C.L.; Ringler, N.J. Binding of vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands. J. Biol. Chem., 1989, 264, 13233-13237.
81. Maheshwari, R.; Levenson, E.A.; Kiick, K.L. Manipulation of electrostatic and saccharide linker interactions in the design of efficient glycopolypeptide-based cholera toxin inhibitors. Macromol. Biosci., 2010, 10, 68-81.
82. Thompson, J.P.; Schengrund, C.-L. Oligosaccharide-derivatized dendrimers: Defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconjugate J. 1997, 14, 837-845.
83. Pukin, A.V.; Branderhorst, H.M.; Sisu, C.; Weijers, C.A.G.M.; Gilbert, M.; Liskamp, R.M.J.; Visser, G.M.; Zuilhof, H.; Pieters, R.J. Strong inhibition of cholera toxin by multivalent GM1 derivatives. ChemBioChem, 2007, 8, 1500-1503.
84. Badjic, J.D.; Nelson, A.; Cantrill, S.J.; Turnbull, W.B.; Stoddart, J.F. Multivalency and cooperativity in supramolecular chemistry. Acc. Chem. Res., 2005, 38, 723-732.
85. Brewer, C.F.; Miceli, M.C.; Baum, L.G. Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharidemediated cellular interactions. Curr. Opin. Struct. Biol., 2002, 12, 616-623.
86. Jencks, W.P. On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. USA, 1981, 78, 4046-4050.
87. Kitov, P.I.; Bundle, D.R. On the nature of the multivalency effect: A thermodynamic model. J. Am. Chem. Soc., 2003, 125, 16271-16284.
88. Lundquist, J.J.; Toone, E.J. The cluster glycoside effect. Chem. Rev., 2002, 102, 555-578.
89. Mammen, M.; Chio, S.-K.; Whitesides, G.M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed., 1998, 37, 2755-2794.
90. Thompson, J.P.; Schengrund, C.-L. Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers. Biochem. Pharmacol., 1998, 56, 591-597.
91. Kitov, P.I.; Sadowska, J.M.; Mulvey, G.; Armstrong, G.D.; Ling, H.; Pannu, N.S.; Read, R.J.; Bundle, D.R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature, 2000, 403, 669-672.
92. Zhang, Z.; Merritt, E.A.; Ahn, M.; Roach, C.; Hou, Z.; Verlinde, C.L.M.J.; Hol, W.G.J.; Fan, E. Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J. Am. Chem. Soc., 2002, 124, 12991-12998.
93. Merritt, E.A.; Zhang, Z.; Pickens, J.C.; Ahn, M.; Hol, W.G.J.; Fan, E. Characterization and crystal structure of a highaffinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. J. Am. Chem. Soc., 2002, 124, 8818-8824.
94. Zhang, Z.; Pickens, J.C.; Hol, W.G.J.; Fan, E. Solution- and solid-phase syntheses of guanidine-bridged, water-soluble linkers for multivalent ligand design. Org. Lett., 2004, 6, 1377-1380.
95. Turnbull, W.B.; Stoddart, J.F. Design and synthesis of glycodendrimers. Rev. Mol. Biotechnol., 2002, 90, 231-255.
96. Arosio, D.; Vrasidas, I.; Valentini, P.; Liskamp, R.M.J.; Pieters, R.J.; Bernardi, A. Synthesis and cholera toxin binding properties of multivalent GM1 mimics. Org. Biomol. Chem., 2004, 2, 2113-2124.
97. Branderhorst, H.M.; Liskamp, R.M.J.; Visser, G.M.; Pieters, R.J. Strong inhibition of cholera toxin binding by galactose dendrimers. Chem. Commun., 2007, 5043-5045.
98. Sisu, C.; Baron, A.J.; Branderhorst, H.M.; Connell, S.D.; Weijers, C.A.G.M.; de Vries, R.; Hayes, E. D.; Pukin, A.V.; Gilbert, M.; Pieters, R.J.; Zuilhof, H.; Visser, G.M.; Turnbull, W.B. The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins. ChemBioChem, 2009, 10, 329-337.
99. Pickens, J.C.; Mitchell, D.D.; Liu, J.; Tan, X.; Zhang, Z.; Verlinde, C.L.M.J.; Hol, W.G.J.; Fan, E. Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer. Chem. Biol., 2004, 11, 1205-1215.
100. Liu, J.; Zhang, Z.; Tan, X.; Hol, W.G.J.; Verlinde, C.L.M.J.; Fan, E. Protein heterodimerization through ligand-bridged multivalent pre-organization: Enhancing ligand binding toward both protein targets. J. Am. Chem. Soc., 2005, 127, 2044-2045.
101. Kitov, P.I.; Lipinski, T.; Paszkiewicz, E.; Solomon, D.; Sadowska, J.M.; Grant, G.A.; Mulvey, G.L.; Kitova, E.N.; Klassen, J.S.; Armstrong, G.D.; Bundle, D.R. An entropically efficient supramolecular inhibition strategy for shiga toxins. Angew. Chem. Int. Ed., 2008, 47, 672-676.
102. Kitov, P.I.; Mulvey, G.L.; Griener, T.P.; Lipinski, T.; Solomon, D.; Paszkiewicz, E.; Jacobson, J.M.; Sadowskaa, J.M.; Suzuki, M.; Yamamura, K.-I.; Armstrong, G.D.; Bundle, D.R. In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the Escherichia coli O157 AB5 toxins. Proc. Natl. Acad. Sci. USA, 2008, 105, 16837-16842.